Changes in spirometry over time in uraemic patients receiving longterm haemodialysis therapy

Pneumologia

Volumn 60, Issue 1, 2011, Pages 36-39

  Kovacevic, Pedja ^a,b   Stanetic, Mirko ^a   Rajkovaca, Zvezdana ^b   Meyei, F Joachim ^c   Vukoja, Marija ^d  

^a University Hopsital Banja Luka   (Germany)

^b UNIVERSITY OF BANJA LUKA   (Bosnia and Herzegovina)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d Institute for Pulmonary Diseases of Vojvodina Sremska Kamenica   (Romania)

Author keywords

Haemodialysis; Spirometry; Uremia

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FIBROSIS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; RISK FACTOR; SPIROMETRY; TIME; TREATMENT OUTCOME; VITAL CAPACITY;

ADULT; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PULMONARY FIBROSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPIROMETRY; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 79958278505     PISSN: 20672993     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Prezent DJ. Effect of uremia and its treatment on pulmonary function. Lung 1990; 168: 1-14.
2. Siafakas NM, Argyrakopuloulos T, et al. Respiratory muscle strength during continuous ambulatory peritoneal dialysis (CAPD). Eur Respir J. 1995; 8: 109-113.
3. Bark H, Heimer D, Chaimovitz C, Mostoslovski M. Effect of chronic renal failure on respiratory muscle strength. Respiration. 1988; 54:153-61.
4. Bush A, Gabriel. Pulmonary function in chronic renal failure: effects of dialysis and transplantation. Thorax 1991; 46: 424-428.
5. Rackow EC, FernEI, Sprung C, Grodman RS. Uremic pulmonary edema. Am J Med 1978; 64: 1084-8. (Pubitemid 8358604)
6. Wallin CJ, Jacobson SH, Leksell LG. Subclinical pulmonary oedema and intermittent haemodialysis. Nephrology dialysis transplantation 1996: (11): 2269-2275. (Pubitemid 26385925)
7. Yigla M, Keidra Z, Safadi I, Tov N, Reisner AS, Nakhoul F. Pulmonary calcification in hemodilaysis patients: Correlation with pulmonary artery preassure values. Kidney Int 2004; 66: 806-810. (Pubitemid 38982025)
8. Yigla M, Nakhoul F, Sabag A, et al. Pulmonary Hypertension in Patients With End-Stage Renal Disease. Chest 2003; 123:1577-1582. (Pubitemid 36549778)
9. Joseph G, MacRae JM, Heidenheim AP, Lindsay RM. Extravascular lung water and peripheral volume status in hemodialysis patients with and without a history of heart failure. ASAIO J 2006; 52: 423-429. (Pubitemid 44174630)
10. Herrero JA, Alvarez-Sala JL, Coronel F, Moratilla C, Gamez C, Sanchez-Alarcos JM, Barrientos A. Pulmonary diffusing capacity in chronic dialysis patients. Respir Med. 2002; 96: 487-92.
11. Kalender B, Erk M, Pekpak MA, Apaydin S, Ataman R, Serdengecti K, Sariyar M, Erek E. The effect of renal transplantation on pulmonary function. Nephron 2002; 90: 72-7. (Pubitemid 34042844)
12. Karacan O, Tutal E, Uyar M, Eyuboglu FO, Sezer S, Ozdemir FN. Pulmonary function in uremic patients on long-term hemodialysis. Ren Fail. 2004; 26: 273-8. (Pubitemid 39050669)
13. Taskapan H, Ulu R, Gullu H, Taskapan MC, Yildirim ZKosar F, Sahin I, Kaya M. Interdialytic weight gain and pulmonary membrane diffusing capacity in patients on hemodialysis. Int Urol Nephrol. 2004; 36:583-6. (Pubitemid 40208042)
14. Karacan O, Tutal E, Colak T, Sezer S, Eyuboglu FO, Haberal M. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis. Transplant Proc. 2006;38:396-400.
15. Lang SM, Becker A, Fischer R, Huber RM, Schiffl H. Acute effects of hemodialysis on lung function in patients with end-stage renal disease. Wien Klin Wochenschr 2006;118:108-13
16. Miller MR, Hankinson J, Brusasco V, et al. ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. (Pubitemid 41079078)
17. Kovacevic P, Matavulj A, Veljkovic S, Rajkovaca Z, Ponorac N, Huskic J. Ventilator Function Improvement in Patients Undergoing Regular Hemodialysis: Relation to Sex Differences. Bos J Basic Med Sci 2006; 6: 29-32.
18. Kovacevic P, Matavulj A, Veljkovic S, Dekic-Cado M, Rajkovaca Z, Ponorac N. Hemodialysis efects on respiratory function. Acta Fac Med Naiss 2004; 21: 119-126.
19. Abassi Z, Nakhoul F, Khankin E, Reisner AS, Yigla M. Pulmonary hypertension in chronic dialysed patients with arteriovenus fistula: pathogenesis and therapeutic prospective. Curr Opin Nephrol Hypertens 2006; 15: 353-360. (Pubitemid 44297976)
20. Pastan S, Bailey J. Dialysis therapy. N Engl J Med 1998; 338:1428-1436.
21. Ifudu O. Care of patients undergoing hemodialysis. N Engl J Med 1998; 339: 1054-1062. (Pubitemid 28457868)
22. Stewart DJ, Levy RD, Cernacek P, et al. Increased plasma endothelin 1 in pulmonary hypertension: marker or mediator of disease. Ann Intern Med 1991; 144: 464-469.
23. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with primary pulmonary hypertension. N Engl J Med 1993; 328:1732-1739. (Pubitemid 23170122)
24. Brooks DP. Role of endothelin in renal function and dysfunction. Clin Exp Pharmacol Physiol 1996; 23: 345-348. (Pubitemid 26171573)
25. Belvisi MG, Stretton CD, Yacoub M, et al. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992; 210: 221-2.
26. Fagan KA, McMurtry IF, Rodman DM. Role of endothelin-1 in lung disease. Respir Res 2001; 2: 90-101. (Pubitemid 34187913)
27. F J Meyer, R Ewert, M M Hoeper, H Olschewski, J Behr, J Winkler, H Wilkens, C Breuer, W Kubler and M M Borst. Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002; 57: 473-476. (Pubitemid 34627977)
28. Kaysen AG. Microinflamatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557.
29. Dawney A, Millar DJ. The pathogenesis and consequences of AGE formation in uremia and its treatment. Cell Mol Biol 1998; 44: 1081-1094.
30. Mimic-Oka J, Simic T, Djukanovic L, Reljic Y, Davicevic Z. Alteration in plasma antioxidant capacity in various degree of chronic renal failure. Clin Nephrol 1999; 51: 233-241. (Pubitemid 29196887)
31. Pomianek MJ, Colton CK, Dinarello CA, Miller LC. Synthesis of tumor necrosis factor ? and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stree. ASAIO J 1996; 42: 52-59. (Pubitemid 26038646)
32. Tielemans C, Husson C, Schurmans T, Gastaldello K, Madhoun P, Delville JP, Marchant A, Goldman M, Vanherweghem JL. Effects of ultrapure and nonsterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int 1996; 49: 236-243. (Pubitemid 26022843)
33. Vanholder R, Ringoir S, Dhond A, Hakim RM. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320-327.
34. Xu J, Zhong NS. The interactio of tumour necrosis factor alpha and endothelin-1in pathogenetic models of asthma. Clin Exp Allergy 1997; 27: 568-573. (Pubitemid 27241656)
35. Alastair G, Stewart PR, Wilson J. Airway wall remodeling in asthma: A novel target for the development of antiasthma drugs. Trends Pharmacol Sci 1993; 14: 275-279. (Pubitemid 23204246)
36. Xu J, Zhong NS. Mechanisms of bonchial hyperresponsiveness: The interaction of endothelin-1 and other cytokines. Respirology 1999; 4: 413-417. (Pubitemid 30016293)
37. Reichenberger F, Schauer , Kellner K, Sack U, Stiehl P, Winkler J. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Lung 2001; 179: 163-174. (Pubitemid 34033112)
38. Ghofrani AH, Voswinckel R, Reichenberger F, Weissmann N, Schemuly R, Seeger W, Grimminger F. Hypoxia-and non-hypoxia-related pulmonary hypertension-established and new thrapies. Cardiovasc Res 2006; 72: 30-40. (Pubitemid 44310648)
39. Miyauchi T, Sugishita Y, Yamaguchi I, Ajisaka R, Tomizawa T, Onizuka M, Matsuda M, Kono I, Yanagisawa M, Goto K, Suzuki N, Matsumoto H, Masaki T: Plasma concentrations of endothelin-1 and endothelin-3 are altered differently in various pathophysiological conditions in humans. J Cardiovasc Pharmacol 17Suppl 7]: S394-S397, 1991.
40. Saito Y, Kazuwa N, Shirakami G, Mukoyama M, Arai H, Hosoda K, Suga S, Ogawa Y, Imura H: Endothelin in patients with chronic renal failure. J Cardiovasc Pharmacol 17Suppl 7]: S437-S439, 1991.
41. Galie N, Manes A, Uguccioni L, et al. Primary pulmonary hypertension insights into pathogenesis from epidemiology. Chest 1998; 114: 184S-194S. (Pubitemid 28435966)
42. Warrens N A, Cassidy M J D, Takahashi K, Ghatei M A, Bloom R S. Endothelin in renal failure. Nephrol Dial Transplant 1990; 5: 418-422. (Pubitemid 20242110)